CannabisNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Secures Health Canada Approval for Totality of Valleyfield Hybrid Greenhouse

The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a leading producer of premium, certified-organic cannabis, today announced its receipt of Health Canada’s approval for the totality of its main Valleyfield hybrid greenhouse. According to the update, TGOD has the flexibility, with all twenty-four zones now licensed, to quickly expand its operations at Valleyfield as the market develops. The company also plans to leverage parts of the newly licensed space to shift a portion of its processing activities currently being handled at Ancaster or intended to be outsourced to third parties. This will assist the company in optimizing costs, accelerating supply chain timelines and reducing bottlenecks in production of high-demand products such as infusers and teas.

To view the full press release, visit http://cnw.fm/j4N8k

About The Green Organic Dutchman Holdings Ltd.

The Green Organic Dutchman Holdings is a premium certified organic cannabis company focused on the health and wellness market. Its certified‐organic cannabis is grown in living soil, as nature intended. The company is committed to cultivating a better tomorrow by producing its products responsibly, with less waste and impact on the environment. Its two Canadian facilities have been built to LEED certification standards and its products are sold in recyclable packaging. In Canada, TGOD sells dried flower and oil, and recently launched a series of next‐generation cannabis products such as organic teas, infusers and vapes. Through its European subsidiary, HemPoland, the company also distributes premium hemp CBD oil and CBD-infused topicals in Europe. By leveraging science and technology, TGOD harnesses the power of nature from seed to sale. TGOD’s common shares and warrants issued under the indentures dated November 1, 2017 and December 19, 2019 trade on the TSX under the symbol “TGOD”, “TGOD.WT” and “TGOD.WS”, respectively, and TGODF trades in the US on the OTCQX. For more information, visit the company’s website at www.tgod.ca.

NOTE TO INVESTORS: The latest news and updates relating to TGODF are available in the company’s newsroom at http://cnw.fm/TGOD

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CannabisNewsBreaks – Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) Hosting Conference Call, Webcast to Discuss Audited Q4 and Full Year 2019 Results

Plus Products (CSE: PLUS) (OTCQX: PLPRF) on Wednesday announced that after markets close on Thursday, May 7, the company will report its audited financial results for the fourth quarter and full year ending December 31, 2019. In addition, the company will also be hosting a conference call and webcast to discuss the financial results and recent corporate highlights on May 7 at 5 PM ET. Plus co-founder and CEO Jake Heimark and chief financial officer Jon Paul will also be conducting a question and answer session on the call. To join the call, dial (866) 220-4156 for the US and Canada toll-free line or (864) 663-5231 for the international line and request the Plus Products earnings call or provide conference ID: 2867687. To view the webcast, visit the website at least 15 minutes prior to the call to register, download, and install any necessary audio software (http://cnw.fm/I0kSs). After the call is finished, there will be an archived audio webcast available for replay on the company’s website.

To view the full press release, visit http://cnw.fm/Yzy19

About PLUS

PLUS is a cannabis and hemp food company focused on using nature to bring balance to consumers’ lives. PLUS’s mission is to make cannabis safe and approachable – that begins with high-quality products that deliver consistent consumer experiences. PLUS is headquartered in San Mateo, CA. For more information, visit the company’s website at www.PlusProducts.com.

NOTE TO INVESTORS: The latest news and updates relating to PLPRF are available in the company’s newsroom at http://cnw.fm/PLUS

About CanadianCannabisWire

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

420 with CNW – THC-A: A Superior Neuroprotectant and Anti-Inflammatory Cannabinoid?

The past few years have been instrumental for cannabis. It has seen a slew of positive legislative changes and more states are willing to look at it objectively, especially in regard to its potential medical benefits. Although the science to back this up is scarce, we now know without a doubt that cannabis produces chemicals called cannabinoids, and they are responsible for its therapeutic abilities.

The two most common ones are THC and CBD. THC is the main active component in marijuana and it is responsible for cannabis’s infamous ‘high.’ CBD, on the other hand, carries most of marijuana’s medical potential and has a wide variety of medical applications. However, cannabinoids aren’t limited to just these two.

Cannabis produces over 100 of them and aside from THC and CBD, there are numerous others including THC-a, CBD-a, CBC, and CBG. Cannabinoids like THC-a, or tetrahydrocannabolic acid, especially, hold their own against CBD in some aspects.

CBD is a powerful anti-inflammatory, but THC-a may be even more potent. It is the inactive form of THC, and it gets converted into the psychoactive chemical when it is heated or burnt. The process also occurs naturally as the plant dries.

Like CBD, there isn’t enough science to definitively say that THC-a is 100% effective against certain conditions. However, there is plenty of anecdotal evidence, and preliminary research has been encouraging.

It is a potent anti-oxidant, and it could hypothetically be used as a neuroprotectant in neurodegenerative conditions like Alzheimer’s, Parkinson’s, Multiple Sclerosis, ALS, and similar conditions. Although there haven’t been any human trials yet, the science behind the theory is sound.

THC-a is also a powerful anti-inflammatory, and it has been found to be 10-20 times more potent than CBD. And while cannabidiol can kill affected cells in high doses, THC-a does not.

One risk with cannabidiol is potentially harmful drug interactions. CBD is broken down in the liver by an enzyme that breaks down many common medications and it can interact with these drugs in potentially dangerous ways. THC-a, on the other hand, is broken down by a relatively lonely enzyme and has limited chances of interacting with any other drugs in your system.

THC-a is also more abundant than CBD. Cannabidiol may be insanely popular, but it makes a small percentage of the total cannabinoids produced by cannabis. Since THC-a is the inactive form of THC, there are larger reserves of it. As long it is extracted before it converts into THC, using a cold extraction method like chilled ethanol, you’ll have a lot more THC-a than CBD.

Although THC-a still isn’t as accessible as cannabidiol yet, this may change with time as more research is done. At the moment, experts recommended a 10-40mg dose over the day, for a couple of weeks for the best results.

It is widely expected that sector players like SinglePoint Inc. (OTCQB: SING) may be doing a lot of work behind the scenes to bring THC-a products to consumers in the near future.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW – Increased Hand Washing Boosts CBD Market

With the coronavirus tearing through the world, most of us are doing our best to avoid being infected. According to medical professionals, the best way to do this is to practice self-isolation and social distancing coupled with thorough and frequent hand washing with soap and water or an alcohol-based sanitizer.

While this has been found to help flatten the curve, the increased hand washing is resulting in dry, itchy, and irritated hands. According to Shari Marcbein, a brand certified dermatologist and clinical assistant professor of dermatology at NYU School of Medicine, the excessive hand washing strips the skin of healthy fats and oils known as sebum, and that dehydrates the skin.

Additionally, 10% of the U.S. population, around 38 million Americans, suffer from eczema, according to the National Eczema Association. This is a medical condition that results in itchy, inflamed, and cracked skin, and it makes washing your hands with soap or an alcoholic sanitizer an absolute nightmare.

That’s where CBD comes in. Sanitizing is necessary to beat the virus, so finding ways to soothe your hands afterward is crucial. As Joshua Zeichner, director of cosmetic and clinical research in dermatology at Mount Sinai Hospital says, “It is important to treat these rashes because, in addition to being itchy, inflamed or raw, the skin is at risk of developing an infection.”

Cannabidiol is a natural medicine with a diverse range of medical applications. It is a potent anti-inflammatory which makes it quite effective against eczema. On top of that, it soothes, moisturizes, and nourishes the skin, allowing it to recover from frequent and abrasive hand washing.

“There are receptors in the skin that interact with cannabinoids that could reduce the symptoms and appearance of atopic dermatitis. These effects happen through a constellation of interactions between phytocannabinoids and our endogenous cannabinoid system (ECS),” says the National Eczema Association.

The ECS is a peripheral nervous system that helps regulate processes like mood, memory, pain, appetite, stress, and immune function, all of which determine the internal balance or homeostasis of the body. “CBD interacts with this system and may help the skin re-establish or maintain homeostasis, the result, in this case, being a reduction in symptoms associated with eczema,” says Mary’s Nutritionals’ Chief Scientist, Jeremy Riggle, Ph.D.

Cornbread Hemp, a Kentucky based CBD company has seen great success with its CBD skin lotion, especially once the virus broke out. The full spectrum CBD lotion works great against chapped and dry hands, and more people are using it to help moisturize and nourish their hands.

With experts saying that the virus might stick around for almost two years, we may see increased CBD lotion sales as people try to keep their hands clean and healthy.

Analysts believe that the cannabis industry, including Round Meadow Holdings Corp. and The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF), is pleased that there is a silver lining to this pandemic that has adversely affected the sector and other industries.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Sugarmade, Inc. (SGMD) Receives $10M in New Orders for Sanitary and Personal Protective Supplies Amidst the Re-Opening of America

Sugarmade (OTCQB: SGMD) today announced its receipt of over $10 million in new orders for consumable sanitary supplies and non-medical personal protective items as America prepares to get back to work. As businesses across the country are scrambling for supplies in preparation to reopen, facing moral and legal obligations to protect their workers, Sugarmade’s CarryOutsupplies.com operating unit is benefiting in helping to meet this demand. “We have never seen anything like this situation. We believe we are in a unique situation relative to the re-opening of America,” Sugarmade CEO Jimmy Chan stated in the news release. “Approximately two months ago we began importing consumable sanitary supplies and non-medical personal protective gear. As it turns out, this was a wise move. We sold out of nearly all of what we received. Fortunately, we have the sourcing and trans-Pacific logistical experience to bring in much larger quantities to help meet the insatiable demand that is developing as business, universities, and government institutions order supplies to protect their workers and customers. We have a lot more product in the supply chain that will soon be headed to our customers.”

To view the full press release, visit http://cnw.fm/CU7cB

About Sugarmade Inc.

Sugarmade is a product and branding marketing company investing in operations and technologies with disruptive potential. More information on Sugarmade can be accessed at: www.Sugarmade.com. Sugarmade sees opportunities in business operations that combine the best areas of on-demand consumer distribution with certain areas of synergistic manufacturing and packaging to create a business model that capitalizes on the many changes in the cannabis industry. The company has made agreements with several market participants, which will be announced within Q1 and Q2 of calendar year 2020. The company views these opportunities as very scalable and capable of producing strong revenue growth for the company.

NOTE TO INVESTORS: The latest news and updates relating to SGMD are available in the company’s newsroom at http://cnw.fm/SUGAR

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) Names New President, Secretary; Appoints New Member to Board of Directors

Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496), a human optimization sciences company focused on applying novel and natural treatment protocols to address a broad range of disorders and deficiencies with an emphasis on psychedelic medicine, today announced the appointment of Pat McCutcheon to the company’s board of directors, effective immediately. McCutcheon is currently the chief executive officer of one of the leading global cannabis companies, MediPharm Labs Corp. (TSX: LABS), and has held senior roles with various large pharmaceutical companies. Champignon also announced the appointment of Matthew Fish, JD as president and secretary. In his private practice as a securities lawyer, Fish has established expansive knowledge regarding public companies, capital markets, and mergers & acquisitions. Fish will utilize his experience to assist SHRM in fast-tracking its North American new clinical entity roll-out. “We are tremendously pleased to have Pat join the Champignon Board,” Champignon CEO and director Gareth Birdsall stated in the news release. “His extensive experience in commercial development across the pharmaceutical industry combined with direct experience operating and scaling highly profitable businesses further strengthens our board with expertise that will accelerate the expansion of our clinical footprint via the establishment of net new clinical entities, as well as industry partnerships for ketamine, psilocybin and MDMA.”

To view the full press release, visit http://cnw.fm/m2mTZ

About Champignon Brands Inc.

Champignon Brands (CSE: SHRM) is focused on the formulation and manufacturing of novel ketamine, anaesthetics and adaptogenic delivery platforms for the nutraceutical and psychedelic medicine while being supported by a leading psychedelics medicines clinic platform. The Company is pursuing the development and commercialization of rapid onset treatments capable of improving health outcomes, such as depression and post-traumatic stress disorder (“PTSD”), as well as substance and alcohol use disorders. Under a collaborative research agreement with the University of Miami’s Miller School of Medicine, the Company is conducting preclinical studies and eventual human clinical trials, with the objective of demonstrating safety and efficacy of the combination of psilocybin and cannabidiol in treating mTBI with PTSD or stand-alone PTSD. Champignon continues to be inspired by sustainability, as its medicinal mushroom-infused SKUs are organic, non-GMO and vegan certified. For more information, visit the company’s website at www.ChampignonBrands.com.

NOTE TO INVESTORS: The latest news and updates relating to SHRM are available in the company’s newsroom at http://cnw.fm/SHRM

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW – How to Read Marijuana Product Labels

Despite its immense popularity, the cannabis industry is still new and relatively unregulated. While federal law classifies cannabis as a controlled substance, over 30 states have legalized cannabis in various capacities. This patchwork legislation makes it difficult for agencies like the U.S. Food and Drug Administration (FDA) to fully regulate the industry.

There are always bad players in such situations. In marijuana’s case, it is companies making unsubstantiated medical claims on their products or delivering contaminated products. That’s why it is crucial you check product labels before making any purchases.

Companies are legally required to send their product to a third-party laboratory for testing, and the results should be made available to consumers. This is proof that the product is safe to use, contains what it says on its labeling and in the correct amounts.

Depending on region-specific labeling laws, producers may publish results on the label or they may provide detailed lab results (a Certificate of Analysis) via a batch number or a QR code. Third-party lab results will typically detail;

Cannabinoids. This is a group of chemicals produced by cannabis, and they are responsible for its physiological and psychological effects. The most abundant ones are THC, which is responsible for marijuana’s infamous high and CBD (cannabidiol), which is said to be medically beneficial.

Minor cannabinoids that may be present include THCa, THCv, CBDa, CBN, CBC, and CBG. Third-party results will show how much of each cannabinoid is present in the product.

Terpenes are also produced by cannabis, and they are responsible for its distinctive flavor and aroma. They work together with THC, CBD, and the other cannabinoids to create unique effects and benefits in what has been dubbed the ‘entourage effect’.

Some products are completely devoid of terpenes while others contain them. Some of the terpenes you may see on lab results include myrcene, limonene, and terpinolene.

Moisture content will also determine how safe the product is. If cannabis bud, for instance, has a high moisture level (over 15%) there is an increased risk of bacteria and fungi. However, if it is too low (less than 5%) the bud will be brittle and dry, taking away from the experience. Labs also test for microbial growth for things like salmonella, E. coli, yeast, and mold in samples with higher moisture content.

Solvents are used in extraction processes, and they can remain in low levels in the product. Different regions have different acceptable levels for various solvents but once they are past a certain level, they can have serious health implications. Labs usually test for propane, butane, benzene, and xylenes.

Heavy Metals may also be present as cannabis absorbs and stores them from fertilizers or contaminated soil. Third parties labs usually flag cadmium, arsenic mercury, and lead as well as several others in the Certificate of Analysis (COA).

A COA is an invaluable resource if you are considering purchasing a marijuana product. Producers that make their lab results easily accessible prove they have nothing to hide, and they are more likely to have safe high-quality products.

Experts say it is no wonder that leading cannabis companies like Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) actively encourage their customers to read the product labels carefully before buying any product.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW – Coronavirus Outbreak Causes Illinois to Delay Issuing 75 Cannabis Dispensary Licenses

The state of Illinois has announced that it will delay awarding 75 licenses for new marijuana dispensaries due to the coronavirus crisis. It joins the number of states who have had marijuana initiatives, from legalization to licensing, disrupted by the outbreak.

On Wednesday last week, the Illinois Department of Financial and Professional Regulation, which regulates dispensaries, announced that it will not award the 75 licenses until Governor J.B. Pritzker’s disaster proclamations end or the state decides on another date.

The governor is expected to sign a new order extending the state’s disaster proclamation through May 30.

Although recreational marijuana sales started on Jan 1, only existing operators were allowed to participate. The state has about 50 dispensaries selling recreational marijuana, and the delay will grant them monopoly status over the state’s mammoth marijuana market. Customers in Illinois spent around $110.2 million on legal cannabis within the first three months of sales.

The 75 Conditional Adult-Use Cannabis Dispensing Organization Licenses were set to be awarded by May 1 but it is now unclear how long the applicants will have to wait. There were more than 700 applications for the 75 available licenses, and many of them were social equity applicants.

These are individuals who have a marijuana-related arrest on their record, live in an area that’s been disproportionately hit by the war on drugs, or meets another qualifier. According to Too Hutchinson, senior adviser to the governor on cannabis control, the Pritzker administration is committed to creating a marijuana industry that reflects the diversity of Illinois residents.

“We recognize that countless entrepreneurs were looking forward to May 1 and the next step it represented for Illinois’s adult-use cannabis industry. However, the ongoing COVID-19 situation has caused delays in this application review process. This executive order will help ensure that we continue to build out this industry in a deliberate and equity centric manner,” she said in a statement.

The applicants who eventually win licenses will be granted 180 days to source a location if they haven’t already. The location will have to be inspected by the state before any commerce can begin.

According to the Chicago Tribune, licenses offer the first path into Illinois’ burgeoning marijuana industry for people who didn’t already operate a cannabis facility. The state would get an influx of tax revenue from increased sales to help cushion it against the pandemic’s economic fallout as well as provide much-needed employment opportunities.

Analysts believe members of the cannabis industry, such as Champignon Brands Inc. (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496), will be disappointed that their aspiring counterparts in Illinois will have to wait for an unknown duration before they can get a go-ahead to start dispensary operations.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Cannabis Strategic Ventures, Inc. (NUGS) Achieves Record-Breaking Sales in April

Cannabis Strategic Ventures (OTCQB: NUGS), an emerging leader in the U.S. cannabis marketplace, today announced that the company achieved record sales during the last week of April. The company reported a significant increase in sales for the month of April, with numbers climbing more than 800% higher than the average monthly totals seen in calendar Q1. NUGS recently doubled its production capacity, enabling the company to continue to take on growing distributor relationships and larger orders in the California cannabis market. “The close of April represents an important signal in terms of business context. We have seen a number of strong signals suggesting a robust acceleration in sales in calendar Q2. But we have clearly been underestimating the extent of that acceleration. Given our move to increase production capacity, we should see an even more impressive close to Q2 and will likely have to further ratchet up our expectations,” Cannabis Strategic Ventures CEO Simon Yu stated in the news release.

To view the full press release, visit http://cnw.fm/jXzJ9

About Cannabis Strategic Ventures

Cannabis Strategic Ventures, Inc. (OTC: NUGS) is one of the largest publicly traded marijuana cultivators in the United States. The company is Los Angeles-based that incubates, develops and partners with category leaders within the cannabis and ancillary sectors. The firm’s NUGS brand experience provides operational and financial strategic partnerships and a range of essential services to emerging and existing cannabis consumer brands. For more information, visit www.CannabisStrategic.com.

NOTE TO INVESTORS: The latest news and updates relating to NUGS are available in the company’s newsroom at http://cnw.fm/NUGS

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – SinglePoint, Inc.’s (SING) Hemp Vertical on Track to Double Sales in Q2 Alongside Launch of 1606 Countertop Display

SinglePoint (OTCQB: SING) announced today that it is starting its second quarter with strong numbers and the focus on continued growth. According to the update, SinglePoint’s Hemp vertical is on track to double sales in Q2 alongside the launch of 1606 Hemp six-pack counter top display. 1606 Hemp has seen a 133% increase in sales growth this quarter, as well as a 233% growth in sales up to this point of the month compared to the same timeframe in the previous month. SinglePoint has placed a focus on self-generated in store placement by hiring professional sales representatives to acquire new stores for the sales of its products over the next four weeks. The company’s goal is to grow 1606 by more than 250 retail accounts throughout multiple states.

To view the full press release, visit http://cnw.fm/9EwBm

About SinglePoint, Inc.

Founded in 2011, SinglePoint, Inc. invests in and acquires brands and companies that will benefit from injection of growth capital and its sales and marketing expertise. The company’s portfolio currently includes solar, hemp and technology applications. SinglePoint is working to grow the company to a multi-national brand. For more information, visit the company’s website at www.SinglePoint.com.

NOTE TO INVESTORS: The latest news and updates relating to SING are available in the company’s newsroom at http://cnw.fm/SING

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.